Compared to traditional immunodeficient strains, such as NOD-SCID and NSG, the BRGSF mouse represents the most immunodeficient model generated to date, with defect of both the murine lymphoid and myeloid compartments, and thus represents a strongly adapted animal model for xenograft of human tumor and/or immune system.

Applications

This next-generation mouse is a unique preclinical model to study:

  • Tumor xenograft (including CDX, PDX)
  • Standard of care therapies (surgery, chemotherapies, radiotherapies, etc.)
  • Cell therapies (including NK, CAR-T cell) efficacy and depletion assessment
  • Human CD34+ hematopoietic stem cell engraftment
  • Human PBMC cell engraftment
  • Complement-dependent cytotoxicity (CDC) studies

BRGSF features

  • Highly immunodeficient (T, B, NK, myeloid cells) due to Rag2, IL-2Rγc and Flk2 KO
  • Highly permissive to patient-derived xenografts (PDXs) and cell line engraftment by virtue of the SIRPαNOD expression and reduced murine myeloid compartment
  • Robustness to radiotherapies, chemotherapies due to BALB/c background and the absence of the SCID mutation
  • A complete, functional complement system makes this a powerful tool for complement-dependent cytotoxicity (CDC) studies
  • Stable phenotype throughout lifespan

FAQ on BRGSF mouse models

1. What is the BRGSF mouse model?

The BRGSF is the most immunodeficient mouse model generated to date, with defects in both myeloid and lymphoid compartments (Rag2-/-, IL 2Rγ-/-, Flk2-/-). Here is its genetic background:

2. What makes the BRGSF an immunodeficient mouse model?

The BRGSF carries multiple genetic defects, including mutations in:

  • The recombination-activating gene 2 (RAG2). Together with RAG1, RAG2 initiates the VDJ recombination, a site-specific recombination process that ensures the generation of a large repertoire of unique antigen receptors on B and T lymphocytes. As such, mutations in RAG2 cause depletion in these immune cells.
  • The gamma chain of the interleukin 2 receptor (IL-2Rγc). The gamma chain is an essential subunit of functional IL-2 receptors, as well as four other interleukins (IL-4, IL-7, IL-9, and IL-15). Mutations in this gene lead to X-linked severe combined immune deficiency (X-SCID), a combined cellular and humoral immunodeficiency characterized by a profound T- and NK-cell deficiency.
  • The fetal liver kinase-2 (Flk2). This is a receptor tyrosine kinase that regulates the development of the myeloid compartment; as such, mutations in Flk2 lead to a strongly reduced myeloid cell compartment.

3. How would you make the most of the BRGSF?

The BRGSF mouse model represents a valuable tool for:

4. Which unique valuable features do BRGSF mice possess?

BALB/c genetic background

As such, these animals represent valuable tools to predict clinical response to certain anticancer drugs, and for long-term transplantation studies. Indeed, contrary to NOD and NOD-derived strains such as NSG and NOG, BRSGF mice do not carry the Prkdc mutation and, therefore, do not show the SCID side effect of high sensitivity to radiation, T-cell leakage, and increased incidence of thymic lymphoma formation.

NOD-specific polymorphic SIRPα

This renders BRGSF mice highly permissive to human cell engraftment. SIRPα is a transmembrane glycoprotein expressed on early hematopoietic progenitors, on myeloid cells such as macrophages and granulocytes, and on dendritic cells and neurons. It binds CD47, an immunoglobulin that acts as a self-marker for macrophages. Importantly, several studies have shown that Cd47−/− mouse hematopoietic cells grafted into wild-type mice, and into mice lacking T, B and NK cells, are rapidly ‘eaten’ by macrophages, as are wild-type cells if the CD47–SIRPα binding is disrupted. Polymorphisms in SIRPα thereby represent a potent genetic determinant of human hematopoietic stem cell engraftment and host survival.

Fully functional complement cascade

Unlike NOG-based strains, where C5A is knockout, BRGSF mice possess a fully functional complement cascade.

5. How do BRGSF mice compare to other immunocompromised mice?

brgsf-nsg


Validation

Related ressources et publications

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No results

Discover related products to

BRGSF

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mouse
HSA
PK/PD
Immunodeficient

HSA/hFcRn-Rag1-KO

This upgraded, immunocompromised Rag1-/- version of our HSA/hFcRn mouse model allows the assessment of compounds' half-life and anti-tumor efficacy in a human tumor model.

Rats
Immunodeficient
Knockout
BTK

Btk rat

Btk Knockout rat to study B-cell malignancies, aberrant B-cell responses, Btk inhibitors for treatments of hematologic cancers or autoimmune diseases.in vivo.

Mouse
HIS
BRGSF
Immunodeficient

BRGSF-A2-HIS

BRGSF-A2-HIS mice possess the most functional reconstituted human immune system. HLA molecules on thymic epithelial cells hinder T-cell cross-reactivity.in vivo.

Rats
Immunodeficient
SDRG

SDRG

The immunodeficient SDRG rat model is a double Knockout for Rag1 and IL-2Rγ genes (Rag1-/- Il2rγ-/-), resulting in a B, T, and NK cell deficiency.

Mouse
BRGSF
HIS
Immunodeficient

BRGSF-HIS

BRGSF-HIS mice possess the most functional reconstituted human immune system currently on the market and are highly relevant for translational research.in vivo.

Immunodeficient BRGSF mouse model

Get in touch about

Let us know how we can help

In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.

From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.